FMC aims for 110,000 U.S. patients to be on Mircera in first-quarter

FRANKFURT (Reuters) - Kidney dialysis provider Fresenius Medical Care (FMC) expects more than 70 percent of eligible U.S. patients to have switched to cheaper alternative anemia treatment Mircera by the end of March, the German group's chief executive said.

http://ift.tt/1oGHuxH

from Reuters: Health News
via animenewspro